An Update on Perinatal Cannabis Use.


Journal

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
ISSN: 1701-2163
Titre abrégé: J Obstet Gynaecol Can
Pays: Netherlands
ID NLM: 101126664

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 11 06 2021
revised: 05 10 2021
accepted: 08 10 2021
pubmed: 1 11 2021
medline: 25 3 2022
entrez: 31 10 2021
Statut: ppublish

Résumé

Since the legalization of non-medical cannabis, many questions have arisen regarding cannabis use during pregnancy. Obstetrical care providers can minimize the harms of prenatal cannabis use using evidence-based information. This commentary describes populations at highest risk for use, the predictors of use, the reasons birthing people continue or stop using cannabis during pregnancy, and short- and long-term outcomes for infants and children exposed to cannabis prenatally. Our goal is to equip providers with knowledge from the literature to inform practical decision-making.

Identifiants

pubmed: 34718147
pii: S1701-2163(21)00770-2
doi: 10.1016/j.jogc.2021.10.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-312

Informations de copyright

Copyright © 2021 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Auteurs

Catherine Grandy (C)

School of Pharmacy, Memorial University of Newfoundland, St. John's, NL.

Jennifer Donnan (J)

School of Pharmacy, Memorial University of Newfoundland, St. John's, NL. Electronic address: jennifer.donnan@mun.ca.

Lisa Bishop (L)

School of Pharmacy, Memorial University of Newfoundland, St. John's, NL.

Archana Vidyasankar (A)

Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL.

Alicia Blackmore (A)

Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH